Model Portfolio – Future: AI in Medicine – Which Stocks Are Interesting Now
Tech giants are entering the health business. But small and medium-sized companies are also now offering investors opportunities - and the possibility of diversification.
Several major tech companies, including Amazon, Alphabet, and Anthropic, are collaborating with pharmaceutical firms to develop new medications using artificial intelligence. This technology has the potential to significantly reduce the time and cost associated with discovering new treatments. Companies such as Alphabet, Amazon, Schrödinger, and Biontech are already involved in this space, with others like Tempus AI, Oxford Nanopore, and Roche also playing important roles.
These companies are working on different parts of the value chain, including producing high-precision sequencing data, collecting and structuring patient data, and evaluating data using AI models. By leveraging AI, some companies, such as Roche, have already seen significant improvements in the success rate of clinical trials.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
